Comparative Study of Histopathology of Hysterectomy Specimen with Dilatation and Curettage and Hysteroscopic-guided Biopsy in Evaluating Perimenopausal and Postmenopausal Bleeding
Citation Information :
Somasundar BM, Shanmugam L. Comparative Study of Histopathology of Hysterectomy Specimen with Dilatation and Curettage and Hysteroscopic-guided Biopsy in Evaluating Perimenopausal and Postmenopausal Bleeding. J South Asian Feder Obs Gynae 2022; 14 (5):527-530.
Aim: This study was done to compare the efficacy of plain cervical dilatation and curettage (D&C) and hysteroscopic-guided biopsy in evaluating endometrial pathology and to compare the histopathology findings of hysterectomy specimen.
Materials and methods: This study was done at the Obstetrics and Gynecology outpatient department (OPD) in Dr Chandramma Dayanand Sagar Institute of Medical Education and Research, Harohalli, Ramanagara, Karnataka, India over a period of 1 year from January 2021 to January 2022. A total of 100 perimenopausal and postmenopausal women complaining of abnormal uterine bleeding in gynecology OPD were included. Those women who are eligible for diagnostic D&C, cervical dilatation and endometrial curettage were done under i.v. sedation in the operation theater (OT) and the curetting was sent for histopathological examination (HPE). Those women who needs hysteroscopy, it was done under short general anesthesia and the sample was sent for histopathologic examination. Patients for whom hysterectomy was indicated following D&C or hysteroscopy would be followed for the histopathological findings.
Results: Our cases range in the age-group of 40–55 years who presented with abnormal uterine bleeding (AUB) without local gynecological cause and with failure of medical treatment for at least 3 months. The mean duration between the endometrial curettage and the hysterectomy being 2.5 weeks. The highest correlation was seen in the endometrial phase, followed by complex and then by simple hyperplasia.
Clinical significance: The main reason for choosing this study is to find the diagnostic modality with higher accuracy so as to avoid unnecessary hysterectomy in patients with AUB.
Mishra S, Panda B. Efficacy of ultrasonography and hysteroscopy and their correlation with endometrial histopathology in a case of abnormal uterine bleeding in late reproductive age. AIMDR 2018:4(5):10–14. https://imsear.searo.who.int/handle/123456789/188258.
El-Ganal HH, Abd-El-Salam MM, Ghanem RM, et al. Role of diagnostic hysteroscopy and histopathology in evaluation of abnormal uterine bleeding. Egypt J Hosp Med 2018:72(7):4765–4771. DOI: 10.21608/EJHM.2018.10109.
Firdous N, Mukhtar S, Bilal S, et al. Role of hysteroscopy and histopathology in evaluating patients with abnormal uterine bleeding. Int J Reprod Contracept Obstet Gynecol 2017;6(2):615–619. DOI: 10.18203/2320-1770.ijrcog20170393.
Sinha P, Yadav N, Gupta U. Use of hysteroscopy in abnormal uterine bleeding: An edge over histopathological examination. J Obstet Gynaecol India 2018;68(1):45–50. DOI: 10.1007/s13224-017-1065-5.
Hemida RA, Zayed AE, Shalaby A, et al. Agreement of histopathological findings of preoperative uterine curettage and hysterectomy specimens. Impact of time factor and hormonal therapy. J Exp Ther Oncol 2013;10:105–168. PMID: 24416990.
Sakhdari A, Moguaddam PA, Liu Y. Endometrial samples from postmenopausal women: A proposal for adequacy criteria. Int J Gynaecol Patnol 2016;35:525–530. DOI: 10.1097/PGP.0000000000000279.
Patil HA, Suresh AP, Mahajan V. MVP J Med Sci 2015;2:26–29. DOI: 10.15306/mvpjms/2015/v2i1/58635.
Das S, Mondal R. Comparison of hysteroscopy and histopathology in diagnosing abnormal uterine bleeding: An experience from a tertiary care centre of eastern India. New Indian J OBGYN 2021;7(2):135–141.
Tate K, Yoshida H, Ishikawa M, et al. Prognostic factors for patients with early stage uterine serous carcinoma without adjuvant therapy. J Gynaecol Oncol 2018;29(3):e34. DOI: 10.3802ligo.2018.29.e34.
Upadhyay A, Tyagi M, Gupta S, et al. Comparative study of hysteroscopy with ultrasonography and it's correlation with histopathology in cases of abnormal uterine bleeding in perimenopausal women. Int J Reprod Contracept Obstet Gynaecol 2022;11:791–797. DOI: 10.18203/2320-1770.ijrcog20220558.
Stock RJ, Kanbour A. Prehysterectomy curettage: an evaluation. Obstet Gynecol 1975;45(5):537–541. PMID: 1124168.
Moller LM, Berger A. prehysterectomy curettage in women with uterine fibromyomata is not worthwhile. Acta Obstet Gynecol Scand 1993;72:374–376. DOI: 10.3109/00016349309021116.